T
he Gram-negative genus Lysobacter comprises a group of ubiquitous environmental bacteria, emerging as a rich resource for discovering new antibiotics (1) . Of them, Lysobacter enzymogenes is the best-studied species and serves as an important biocontrol resource that has an efficient antagonistic effect on pathogenic filamentous fungi and oomycetes and plant parasitic nematodes (2) (3) (4) (5) . The antagonistic effects of this species are partly due to production of a polycyclic tetramate macrolactam (PTM)-type antifungal secondary metabolite, called heat-stable antifungal factor (HSAF), whose structure is remarkably different from structures of fungicides on the market (6, 7) . The HSAF pks and nrps genes that code for a hybrid polyketide synthase (PKS) and a nonribosomal peptide synthetase (NRPS) are responsible for HSAF biosynthesis in L. enzymogenes (8, 9) . Although HSAF has great potential to be developed as a biopesticide or antifungal drug, the original yield (1.8 g/ml) of HSAF in L. enzymogenes is relatively low even in HSAF-inducing medium (4, 8) . This fact restricts the extensive application of HSAF not only in the control of plant diseases but also in the inhibition of animal pathogens, especially in the case of antibiotic resistance (10, 11) . Based on our knowledge, in addition to heterologous expression of the HSAF biosynthetic gene cluster (9) , artificial synthesis, and optimized fermentation, understanding the regulation mechanism of HSAF biosynthesis is also greatly beneficial in constructing highyield HSAF strains that improve the production of HSAF.
In order to reach this goal, we have identified three key transcription factors (TFs) that control HSAF production. These include the LuxR family protein LesR (a negative regulator), the global regulator Clp (a positive regulator), and the TetR family protein LetR (a negative regulator) (12) (13) (14) . Apart from these regulators, we also found smallmolecule metabolites, such as diffusible signal factor (DSF; a type of fatty acid compound) and diffusible factor (DF), that participate in the biosynthesis of HSAF (15) . We along with our collaborators further showed that the RpfC/RpfG two-component system and Clp mediate the DSF signaling pathway and that L. enzymogenes LysR (LysR Le ) is involved in the DF regulatory cascade (16) . The DF was recently identified as 4-hydroxybenzoic acid (4-HBA) in L. enzymogenes, and this molecule is predicted to be produced by a wide range of bacterial species (16) . The L. enzymogenes 4-HBA is synthesized by LenB2 (a pteridine-dependent dioxygenase-like protein) using chorismate, the end product of shikimate pathway, as the substrate (16) . LysR Le links the 4-HBA cascade to HSAF synthesis because, on one hand, according to our recent work (16) , LysR Le could bind to the lafB gene (the originally described HSAF PKS/NRPS gene) promoter (also called the HSAF promoter, abbreviated as pHSAF) and, as a result, directs expression of HSAF biosynthetic genes and HSAF production; on the other hand, LysR Le interacts with 4-HBA directly. Binding with 4-HBA appears to partly promote the binding of LysR Le to pHSAF in vitro. However, at this moment we cannot conclude that binding of 4-HBA affects the binding of LysR Le to pHSAF, which would explain the change in HSAF output due to transcriptional activation (16) . Our previous findings raise a great possibility that 4-HBA may be involved in stabilizing an LysR Le -DNA (pHSAF) complex with an unidentified protein in L. enzymogenes (16) . Nevertheless, these earlier findings provide a first TF (LysR Le ) linking 4-HBA regulation to HSAF biosynthesis in L. enzymogenes.
The objective of this study was to identify new potent TFs within the 4-HBA regulatory pathway that control HSAF levels and further dissect their genetic/biochemical relationship with LysR Le . Here, we show that LarR (Le4806), an MarR family protein, is the second regulator connecting the 4-HBA cascade to HSAF synthesis. First, 4-HBA negatively regulates the transcription of larR; second, LarR positively controls HSAF levels by direct binding to pHSAF, similar to that of LysR Le ; third, larR transcription is positively controlled by LysR Le as LysR Le could bind to the larR promoter, but LarR failed to directly bind to the lysR Le promoter. Finally, we show that although LysR Le and LarR both serve as key components of the 4-HBA regulatory pathway, both regulators appear to employ independent mechanisms of modulating HSAF biosynthesis. Therefore, our results reveal that antifungal antibiotic HSAF biosynthesis in L. enzymogenes is modulated by the interplay of two transcription factors (LysR Le and LarR) and a Moreover, mutation of larR did not affect the growth ability of the wild type in the test HSAF-inducing medium (Fig. S2B) . Finally, we performed detailed sequence analyses and found that LarR contains all conserved domains or motifs expressed by the well-studied MarR family proteins (Fig. S3 ), confirming that LarR is an MarR-like protein.
Taken together, these results strongly suggest that LarR participated in regulating the biosynthesis of HSAF.
According to our earlier report (15) , larR transcription is negatively controlled by LenB2. To validate this finding, we performed a promoter activity assay. The recombined construct consists of the larR promoter and a promoterless glucuronidase (GUS) gene, uidA. This construct (p-larR) was introduced into the wild-type OH11 and the lenB2 mutant. We found that the larR promoter exhibited significantly higher promoter activity (GUS activity) in the background of the lenB2 deletion than in the OH11 wild-type strain ( Fig. 2A) , which is in agreement with our earlier finding mentioned above (15) . LenB2 could catalyze chorismate to generate 3-HBA and 4-HBA, whereas only 4-HBA is related to the biosynthesis of HSAF (16) . Therefore, only 4-HBA at a concentration of 1 M was added to the culture medium of the ΔlenB2(p-larR) strain because such a low concentration of 4-HBA is sufficient to act as a diffusible factor in restoring the lenB2 mutant to produce wild-type HSAF (16) . In accordance with this, applying 4-HBA to the ΔlenB2(p-larR) mutant significantly reduced the larR promoter activity to a level similar to that of the wild-type OH11, while supplementation of 3-HBA in the culture medium of the ΔlenB2(p-larR) mutant had only a minor effect ( Fig. 2A) , suggesting that 4-HBA plays a key role in suppressing larR transcription. The empty plasmid pSS122 was also introduced into the culture medium of the wild-type OH11 or ΔlenB2 strain to serve as a negative control in the testing of promoter activity. The strains that contained the empty vector displayed almost no GUS activity regardless of the presence or absence of 4-HBA or 3-HBA ( Fig. 2A) . Moreover, quantitative reverse transcription-PCR (qRT-PCR) assays showed that the molecule 4-HBA repressed larR expression in the background of an lenB2 gene deficiency, but 3-HBA did not perform such a function under similar test conditions (Fig. 2B ). In conclusion, these results collectively suggest that LarR is involved in regulating HSAF biosynthesis and that larR transcription is negatively controlled by 4-HBA in L. enzymogenes. LarR is within the 4-HBA regulatory pathway and directly binds to the HSAF promoter. The above results suggest that LarR is a downstream component of the 4-HBA regulatory cascade in modulation of HSAF biosynthesis. To provide more supporting evidence, we generated a mutant (ΔlenB2 ΔlarR strain) lacking both larR and lenB2 (Table 1) , and its identity was confirmed by RT-PCR (Fig. S4A) . The ability of this double mutant to produce HSAF was tested. As expected, deletion of lenB2 and larR almost completely impaired HSAF production ( Fig. 3 and S4B ). Then, single-gene complementation of the ΔlenB2 ΔlarR double mutant was accomplished by introducing plasmid-borne lenB2 or larR (Fig. S4A) . The results showed that individual introduction of larR into the ΔlenB2 ΔlarR double mutant significantly rescued HSAF production deficiency to almost the wild-type level, whereas the single introduction of lenB2 did not yield a similar result ( Fig. 3 and S4B) . As a control, transformation of an empty vector did not restore the HSAF yield. These data suggest that larR is downstream of lenB2 in vivo in L. enzymogenes. Subsequently, we added 3-HBA and 4-HBA to the culture medium of the double mutant in vitro and tested HSAF production. The results, as shown in Fig. 3 and S4B, were consistent with those of the ΔlenB2 ΔlarR (lenB2) strain, suggesting that in the absence of LarR, addition of 4-HBA could not rescue HSAF production deficiency, providing another piece of evidence to highlight the importance of LarR in the 4-HBA regulatory cascade controlling HSAF production. Taken together, the results reveal that LarR was functionally located in the 4-HBA regulatory pathway and modulated HSAF production.
How does LarR control HSAF biosynthesis? To address this question, we tested whether LarR has an ability to bind pHSAF, resulting in directing HSAF gene expression and HSAF production. To test this hypothesis, we used a bacterial one-hybrid reporter system to test the direct binding of LarR to pHSAF. As shown in Fig. 4A , we clearly observed that the transformed Escherichia coli strain that contained both LarR and pHSAF grew very well on selective medium, as did the positive control, whereas the negative control did not successfully grow under similar conditions. This result reveals that direct binding of LarR to pHSAF occurred under the test conditions. To further verify the above finding, an electrophoretic mobility shift assay (EMSA) was carried out.
FIG 3
LarR is a downstream component of the LenB2 regulatory pathway controlling HSAF production in L. enzymogenes OH11. Single introduction of larR, but not lenB2, rescued the deficiency of the double mutant (ΔlenB2 ΔlarR strain) in producing HSAF. Addition of 3-HBA or 4-HBA to the double mutant had no effect on this function. ΔlenB2 ΔlarR, strain with deletion of both lenB2 and larR; ΔlenB2 ΔlarR (lenB2), complementation of lenB2 in the ΔlenB2 ΔlarR strain; ΔlenB2 ΔlarR (larR), complementation of larR in the ΔlenB2ΔlarR strain; ΔlenB2 ΔlarR(pBBR), the ΔlenB2 ΔlarR mutant containing an empty vector, pBBR1-MCS5. Data of triplicate experiments are shown. **, P Ͻ 0.01. Fig. 4C , the concentrationdependent protein-DNA complex formation that is triggered by LarR was evidently detected (from 0.1 to 2 M) and could be specifically and competitively inhibited by an unlabeled HSAF promoter probe (cold probe) at a 100-or 200-fold excess concentration. To further validate the binding specificity of LarR to pHSAF, we selected the promoter region of le1974 (p1974; 295 bp) as a new probe to test whether it could competitively inhibit LarR-pHSAF complex formation. le1974 encodes a GGDEF domaincontaining protein potentially responsible for synthesizing c-di-GMP, an intracellular nucleotide second messenger (17) . To the best of our knowledge, p1974 should be unrelated to the binding capacity of LarR to pHSAF. Our results showed that addition of p1974 at different concentrations into the EMSA mixture containing LarR and pHSAF did not inhibit formation of the complex LarR-pHSAF (Fig. S5 ). In agreement, LarR could not bind to p1974 under the in vitro EMSA conditions (Fig. S5 ). These discoveries, together with the results of HSAF yield (Fig. 1B) , powerfully support the hypothesis that LarR could specifically bind to the HSAF promoter and regulate HSAF biosynthesis.
His-tagged LarR protein was purified (Fig. 4B). As shown in
LysR Le could directly bind to the larR promoter. The above results provide strong evidence to show that LarR is a second key TF, in addition to LysR Le , within the 4-HBA cascade regulating HSAF synthesis. Thus, it is of great interest to question the relationship between LysR Le and LarR. As both TFs could bind to the HSAF promoter, we first investigated whether there is an interaction between the two factors in the binding of the HSAF promoter. For this purpose, a BacterioMatch II bacterial two-hybrid experiment was performed, as described in detail in Materials and Methods. Our results show that the transformed E. coli strain that contained both the LarR and LysR Le proteins did not grow any more on the selective medium, but the positive control grew well (Fig.  S6) . These results suggest that LarR and LysR Le may not interact with each other during their binding to the HSAF promoter.
Since 4-HBA affects larR transcription as described above ( Fig. 2A) , we investigated whether 4-HBA could control larR transcription via LysR Le because LysR Le is the 4-HBA receptor and has a DNA-binding domain (16) . To test this hypothesis, we first tested the potential binding of LysR to the larR promoter (pLarR) by employing the bacterial one-hybrid reporter system described above. As shown in Fig. 5A , we clearly observed coli. Experiments were performed according to the procedures described in the Materials and Methods section. BOH-CK(ϩ), cotransformant containing pBX-R2031 and pTRG-R3133, used as a positive control; pTRG/pHSAF, cotransformant containing pBXcmT-lafB and the empty pTRG, serving as a negative control; pTLarR/pHSAF, cotransformant possessing both pTRG-larR and pBXcmT-lafB (Table 1) . Ϫ3AT-Str r , plate without selective medium; ϩ3ATϩStr r , plate with selective medium. (B) SDS-PAGE of the Histagged, purified LarR, as indicated. Lane M, molecular mass marker. (C) LarR bound to the HSAF promoter (pHSAF) in vitro as determined by an EMSA. The free DNA (the labeled pHSAF) and protein-DNA complex are indicated by arrows. The unlabeled probe (cold probe) at a 100-or 200-fold excess to the reaction mixtures can efficiently and competitively inhibit the binding of LarR to the labeled DNA probe (pHSAF).
that the transformed E. coli strain that contained both the LysR Le regulator and pLarR grew very well on the selective medium, as did the positive control; however, the negative control did not successfully grow under similar conditions. This result indicated that direct binding of LysR Le to pLarR occurred under the test conditions.
To better verify the above findings, an EMSA was carried out. As shown in Fig. 5B , concentration-dependent protein-DNA (pLarR) complex formation, triggered by LysR Le , was obviously detected (from 0.01 to 0.5 M) and could be competitively repressed by an unlabeled larR promoter probe (cold probe) at a 100-or 200-fold excess concentration, suggesting that LysR Le could specifically bind to pLarR in vitro. As further supporting evidence, we found that p1974 at different concentrations could not inhibit LysR Le -pLarR complex formation (Fig. S7) . Consistent with this, LysR Le failed to bind p1974 under the in vitro EMSA conditions (Fig. S7) . Next, given that LysR Le is the receptor of 4-HBA (16), a series of different concentrations of 4-HBA was added to the EMSA system to test whether 4-HBA enhances or represses the binding of LysR Le to pLarR. The results (Fig. S8) showed that 4-HBA at all test concentrations neither enhanced nor repressed the interaction of LysR Le with pLarR; these results matched those of the negative control, 3-HBA. These data imply that LysR Le could bind to pLarR without the influence of 4-HBA or 3-HBA in vitro. It is also important that LarR could not bind to the lysR Le promoter under the in vitro EMSA conditions (Fig. S9) . Taken together, our results showed that LysR Le could specifically bind to pLarR, suggesting that LysR Le may control the transcription of larR (see below).
LysR Le and 4-HBA play opposite roles in larR transcription. To explore whether LysR Le has a regulatory effect on larR transcription, we quantified the relative expression of larR in the lysR Le mutant by qRT-PCR. The results (Fig. 6) showed that, compared to wild-type OH11, the larR expression in the lysR Le mutant was significantly low, suggesting that LysR Le positively regulates larR transcription. This finding is in contrast to the case of 4-HBA, where 4-HBA negatively controls larR transcription. This obser- (Table 1) . pLarR, the larR promoter described in the text; Ϫ3AT-Str r , nonselective medium plate; ϩ3ATϩStr r , selective medium plate. vation prompted us to determine the coregulatory effect of 4-HBA and LysR Le . We thus generated a double mutant lacking both lenB2 and lysR Le (Table 1) . Surprisingly, we found that larR expression in this double mutant was significantly higher than that in the wild-type OH11 (Fig. 6 ). Adding 4-HBA but not 3-HBA could remarkably suppress larR expression in the background of double mutations (Fig. 6) . These results collectively revealed that 4-HBA and LysR Le play opposite roles in larR transcription, with 4-HBA having a bigger effect.
LysR Le and LarR appear to independently regulate HSAF biosynthesis. All of the results described above suggest that both LarR and LysR Le are key regulators of the 4-HBA cascade in modulating HSAF biosynthesis, where 4-HBA and LysR Le control the transcription of larR in opposite ways, suggesting that LysR Le and LarR may regulate HSAF production independently. To test such a hypothesis, a double mutant (ΔlarR ΔlysR Le strain) having deletions of both larR and lysR Le was generated (Table 1) , followed by testing of its HSAF yield. As shown in Fig. 7 , we observed that this double mutant almost lost the ability to produce HSAF; its HSAF yield was lower than that of the larR or lysR Le single mutant. Single introduction of the plasmid-borne larR or lysR Le into this double mutant had no visible effect on rescuing the HSAF production deficiency, suggesting that LysR Le and LarR may independently regulate HSAF production at the genetic level.
DISCUSSION
4-HBA is a newly identified diffusible factor that regulates antifungal antibiotic HSAF biosynthesis in L. enzymogenes (16) . This chemical molecule is further predicted to be widely produced by a diverse range of bacterial species (16, 18) , but the functionality and underlying mechanism remain poorly understood. In L. enzymogenes, we previously showed that LysR Le , an LysR family TF, could serve as the 4-HBA receptor mediating the 4-HBA functional performance (16) . Here, we have identified LarR, a member of the MarR protein family, as a second TF participating in 4-HBA-dependent HSAF biosynthesis, whereby 4-HBA and LysR Le have opposite regulatory effects on larR transcription, with 4-HBA having a bigger effect. These findings establish a bridge to connect one diffusible molecule (4-HBA) to two different types of TFs (LysR Le and LarR) in control of the same phenotype (HSAF production) in L. enzymogenes. Our results thus show that the biosynthesis of a unique secondary metabolite (HSAF) in an agriculturally important bacterium (L. enzymogenes) is controlled by the interplay of two TFs with 4-HBA, a conserved bacterial chemical molecule, which expands our current understanding of the working mechanism used by 4-HBA in bacteria. Our findings may trigger additional studies in 4-HBA-producing bacteria. The fundamental knowledge generated from the present study is greatly helpful in improving HSAF yield by supplying 4-HBA as a direct fermentation supplement and/or by generating higher-HSAF-producing strains via genetic and metabolic engineering of the regulators within the 4-HBA regulatory pathway.
The MarR family proteins are a large group of TFs widely distributed in bacterial and archaeal domains (19) . This group of protein regulators could control bacterial detoxification in response to multiple antibiotics, toxic chemicals, or both (20, 21) . Here, we identify LarR, an MarR-like protein that regulates the biosynthesis of HSAF, an antifungal secondary metabolite, via a direct binding mechanism to the HSAF promoter. This finding associates an MarR-like protein with the area of natural product (HSAF) biosynthesis, expanding the role of MarR family proteins in bacteria. As documented previously, MarR-like proteins prefer to form homodimers to bind gene promoter regions via their winged helix-turn-helix (wHTH)-type DNA binding domains, leading to control of expression of the respective genes (22) (23) (24) (25) . The protein-DNA interactions could be affected by specific phenolic compounds/ligands, such as salicylate, ethidium, and benzoate (22, 26) . Earlier reports, along with our finding that LarR is within the 4-HBA regulatory pathway and could control HSAF production by directly binding to the HSAF promoter, raise a possibility that 4-HBA, a phenolic compound, may serve as the ligand of LarR. However, our results did not support this idea because the microscale thermophoresis (MST) data show no binding of LarR to 4-HBA (see Fig. S10 in the supplemental material). We further found that several 4-HBA structural analogs, including 3-HBA (3-hydroxybenzoic acid), 2-HBA (2-hydroxybenzoic acid), 3,4-HBA (3,4-hydroxybenzoic acid), 3,5-HBA (3,5-hydroxybenzoic acid), and 2,5-HBA (2,5-hydroxybenzoic acid) all failed to interact with LarR (Fig. S10) . These findings collectively suggest that an unidentified phenolic ligand or other types of ligand may interact with LarR in L. enzymogenes. Thus, searching additional ligands of LarR will be the focus of our future study, which will facilitate our deep understanding of the underlying mechanism involved in the regulation of HSAF biosynthesis by LarR.
A notable finding of the present study was that LysR Le , the 4-HBA receptor, positively modulates larR transcription by directly binding to its promoter, establishing a genetic bridge to connect these two TFs that are both within the 4-HBA regulatory pathway. However, the binding of LysR Le to the larR promoter (pLarR) was not affected by 4-HBA in vitro (Fig. S8) although LysR Le binds 4-HBA directly (16) . The mechanism underlying such a phenomenon is unclear at this time, but it is possible that under the in vivo conditions, the LysR Le -pLarR complex may be affected by 4-HBA in combination with an unidentified protein in L. enzymogenes. Testing such a possibility is in progress in our laboratory. Although LysR Le established cross talk with larR by binding to its promoter (Fig. 5) , LarR did not seem to perform similarly with lysR Le as LarR failed to bind the lysR Le promoter (Fig. S9) . Furthermore, LarR is also not likely to interact with LysR Le , as determined by a bacterial two-hybrid assay (Fig. S6) . Based on our present understanding, it is thus likely that LarR did not establish cross talk with LysR Le by binding to the lysR Le promoter or interacting with LysR Le . Another interesting observation made in the present study was that LysR Le and 4-HBA play opposite roles in larR transcription. LysR Le promoted the transcription of larR by directly binding to its promoter ( Fig. 5 and 6 ), while 4-HBA suppressed the transcription of larR (Fig. 2) . The repression of larR transcription by 4-HBA is likely to be independent of LysR Le as addition of 4-HBA could significantly decrease larR transcription in the background of the lenB2 and lysR Le double mutation in the absence of LysR Le (Fig. 6 ). These findings suggest that an unknown factor, probably independent of LysR Le , may mediate inhibition of larR transcription by 4-HBA in L. enzymogenes. Thus, it is possible that 4-HBA may utilize two independent pathways to control HSAF production in L. enzymogenes. One is mediated by LysR Le , whereby 4-HBA directly interacts with LysR Le and appears to partly enhance LysR Le binding to pHSAF in vitro, leading to direct HSAF production (16) . The other is LarR dependent. In this case, 4-HBA is likely to employ unidentified factor(s) (i.e., 4-HBA binding protein), probably independent of LysR Le , to suppress larR transcription. To support this idea, our genetic data further show that regulation by LysR Le and LarR of HSAF production was independent at a genetic level (Fig. 7) . However, at this time, it is unclear whether the two regulators (LysR Le and LarR) compete with each other in their binding to pHSAF. Addressing this and related issues, i.e., mapping the binding sites of LysR Le and LarR in pHSAF, is absolutely necessary for future study. It is also of great interest to understand why 4-HBA needs to adopt two different types of TFs (LysR Le and LarR) to coordinate HSAF biosynthesis. We do not know the exact answer, but it is likely that perhaps the two TFs play regulatory roles at different times and/or cell localizations as well as under different conditional stimulus responses. Such hypothesized molecular strategies may efficiently enable L. enzymogenes to acquire flexibilities or adaptabilities in determining when and how to generate HSAF via the 4-HBA regulatory network. In summary, we expanded the proposed model of 4-HBA in regulating HSAF biosynthesis (Fig. 8 ). In this model, LenB2 uses chorismate, the end product of shikimate pathway, to produce 4-HBA (16) . This molecule further employed two different types of TFs to mediate the regulation of 4-HBA in the control of HSAF production. One TF is LysR Le , which could bind the HSAF promoter and thereby direct HSAF biosynthetic gene expression and HSAF production (16) . In this process, 4-HBA interacts with LysR Le to partly enhance the binding of LysR Le to the HSAF promoter (16) . The other TF is LarR, which can also bind to the HSAF promoter, but LarR did not bind 4-HBA. 4-HBA negatively controls larR transcription, probably via an uncharacterized factor, while LysR has a positive effect on larR transcription by directly binding to its promoter region. Our results thus suggest that the interplay of 4-HBA with two different TFs plays a key role in regulating HSAF biosynthesis in L. enzymogenes, which has not been reported in other 4-HBA-producing bacteria.
MATERIALS AND METHODS
Bacterial strains, plasmids, and growth conditions. The bacterial strains and plasmids that were used in this study are listed in Table 1 . Escherichia coli strains DH5␣, XL1-Blue MRF= Kan, and BL21(DE3) were used for plasmid construction, bacterial one-and two-hybrid assays, and protein expression, respectively. All E. coli strains that were used for plasmid construction were usually grown in Luria broth (LB) at 37°C, supplemented with kanamycin (Km; 25 g/ml) and gentamicin (Gm; 25 g/ml) or 5-bromo-4-chloro-3-indolyl-␤-D-galactopyranoside (X-Gal; 100 g/ml) as needed for solid and liquid media. Lysobacter enzymogenes strains were grown in LB medium or 1/10 tryptic soy broth (TSB) at 28°C. When required, antibiotics were added to the medium to the following final concentrations: kanamycin, 100 g/ml; Gm, 150 g/ml.
Promoter activity assay. The promoter region of lafB, also called the HSAF promoter (pHSAF), was amplified by PCR and cloned into the promoter-probe plasmid pSS122 (Table 1) , which carries a promoterless uidA gene that encodes GUS activity (27) . This combined construct was transformed into the wild-type OH11 and its derivatives by electroporation. Next, overnight cultures of strains containing constructed reporter plasmids in the HSAF-inducing medium (10% TSB) were centrifuged at 12,000 rpm at 4°C for 3 min, and the cells were collected. Then, cells were resuspended in 600 l of GUS buffer (50 mM sodium phosphate, pH 7.0, 1 mM EDTA, and 14.3 mM ␤-mercaptoethanol), and 23 l of 3% Triton X-100 and sodium lauroyl sarcosinate was added. The mixture was incubated at 30°C for 10 min. Last, 100 l of 25 mM p-nitrophenyl-␤-D-glucuronic acid (PNPG) (Sigma, USA) was added. Time for all test sample reactions in this assay is less than 10 min, but the precise time for each sample varied. During the assays, when a yellow pigment developed for each sample, 280 l of Na 2 CO 3 solution (1 M) was added to stop the reaction, and the respective reaction time for each sample was immediately recorded in seconds. The promoter activity was calculated as described previously (27) . The biological experiments were performed in triplicate, and each biological replicate was assayed three times to reduce technical error.
Bacterial one-hybrid assay. The bacterial one-hybrid reporter system was shown to efficiently test physical interactions between the transcription factors and the promoter of target genes (28, 29), as One TF is the reported LysR Le , which could bind the HSAF promoter, thus directing HSAF biosynthetic gene (i.e., lafB) expression and HSAF production (16) . In this process, 4-HBA may partly enhance the binding of LysR Le to the HSAF promoter (16) . The other is LarR, presented in this study, which can also bind to the HSAF promoter; however, LarR did not bind 4-HBA. 4-HBA negatively controls larR transcription, probably via an uncharacterized factor (indicated by a question mark), while LysR has a positive effect on larR transcription by directly binding to its promoter region. LarR failed to bind the promoter of lysR Le . Thus, the interplay of 4-HBA with two TFs within its regulatory cascade plays a key role in regulating HSAF biosynthesis in L. enzymogenes, which has not been discovered in other 4-HBA-producing bacteria. TCA, tricarboxylic acid.
exemplified by the interaction between LarR and its target DNA (pHSAF) in the present study. As described previously, the bacterial one-hybrid reporter system consisted of three modules. The plasmids pBXcmT and pTRG were separately used for cloning the bait DNA and expressing a target protein. The E. coli XL1-Blue MRF= Kan strain (Table 1) is the host strain used to propagate the recombined pBXcmT and pTRG vectors (28, 29) . In the present study, the HSAF promoter region (491 bp) of L. enzymogenes OH11 was cloned into pBXcmT, generating the recombinant vector pBXcmT-lafB (Table 1 ); in addition, the coding region of larR (717 bp) was cloned into pTRG, creating the final construct pTRG-larR ( Table  1 ). The vectors pBXcmT-lafB and pTRG-larR were cotransformed into the XL1-Blue MRF= Kan strain. If direct physical binding occurred between larR and the HSAF promoter, the positively transformed E. coli strain that contained both pBXcmT-lafB and pTRG-larR was expected to grow well on the selective medium, which is a minimal medium (M9)-based medium that contains 5 mM 3-amino-1,2,4-triazole (3-AT), 8 g/ml streptomycin (Str), 12.5 g/ml tetracycline, 34 g/ml chloramphenicol, and 30 g/ml kanamycin, as described previously (28, 29). Moreover, a cotransformant containing the vectors pBX-R2031/pTRG-R3133 served as a positive control (28), while the cotransformant containing the empty pTRG and pBXcmT-lafB plasmids was used as a negative control in the present study. All of these cotransformants were spotted onto selective medium and grown at 28°C for 3 or 4 days, at which point they were photographed.
Genetic methods. A double-crossover homologous recombination strategy was used to generate an in-frame deletion of the gene of interest (GOI) in L. enzymogenes, as described previously (30) . In brief, two flanking regions of the GOI were generated by PCR amplification using various corresponding primer pairs (Table 2 ) and cloned into the respective sites of the suicide vector pEX18Gm (Table 1) (31) . The final constructs were transformed into wild-type OH11 or its derivatives by electroporation. Next, Lysobacter transformants on the LB plates were selected by adding Km (100 g/ml) and Gm (150 g/ml) in the absence of sucrose. Positive colonies were further cultivated on LB plates that contained 10% (wt/vol) sucrose and Km (100 g/ml) to select for the correct construct that was generated by a second crossover event. The final mutants were confirmed by PCR and sequencing (see Fig. S1A in the supplemental material).
For complementation, a plasmid-borne method was utilized to generate the complemented strains, as described previously (12, 15) . In brief, the DNA fragment that contained the full-length GOI and its predicted promoter region was amplified by PCR with different conjugated primer pairs (Table 2) and cloned into the broad-host-range vector pBBR1-MCS5 (Table 1 ) (32). The final construct was transformed into competent cells of the GOI mutant by electroporation to generate the corresponding complemented strains; the identity of these strains was confirmed by PCR with the primer pairs that are shown in Table 2 . HSAF extraction and quantification. Extraction and quantification of the antifungal factor HSAF from various Lysobacter strains by high-performance liquid chromatography (HPLC) (Agilent 1260; USA) were performed as described previously (7, 8, 15) . HSAF was extracted from 25-ml L. enzymogenes cultures that were grown in 1/10 TSB for 48 h at 28°C with shaking at 200 rpm. HSAF was detected using HPLC and quantified per unit of optical density at 600 nm (OD 600 ) as described previously (7, 13, 15) . Three biological replicates were used, and each was analyzed in three technical replicates.
RT-PCR and q-RT PCR. Reverse transcription-PCR (RT-PCR) was performed as described previously (12, 15, 16) . Briefly, the wild-type OH11 L. enzymogenes strain and its derivatives were cultivated in 1/10 TSB until the OD 600 reached 1.0. The cells of each strain were collected by centrifugation (13,000 rpm) at 4°C for 1 min. Total RNA from these cells was extracted using a bacterial RNA kit (catalog no. R6950-01; Omega, China) according to the manufacturer's instructions. To remove genomic DNA, the eluted RNA samples were treated with RNase inhibitors and DNase I (catalog no. E1091; Omega, China). RNA integrity was examined by electrophoresis using 1.2% agarose gels. Then, 2 g of each RNA sample was chosen for cDNA synthesis using a PrimeScript RT reagent kit with genomic DNA (gDNA) eraser (catalog no. RR047A; TaKaRa, Japan). The subsequent semiquantitative RT-PCR and quantitative RT-PCR (qRT-PCR) assays were performed to amplify the 16S rRNA gene and the GOI with the primer pairs listed in Table  2 ; the 16S rRNA gene was used in this study as an internal control as described previously (12, 15) .
Protein expression and purification. Expression and purification of the target protein were performed as described previously (14, 16) . In brief, larR was amplified by PCR with the primer pairs listed in Table 2 . After enzymatic digestion (NdeI/HindIII), this gene was cloned into a pET-30a vector for protein expression in E. coli strain BL21(DE3) ( Table 1 ). The resultant strain was cultivated in LB broth (containing Km at 30 g/ml) overnight at 37°C. Then, a total of 2 ml of overnight culture was transferred into 300 ml of fresh LB medium that contained 30 g/ml Km and was then grown at 37°C with shaking at 200 rpm until an OD 600 of 0.6 was reached. Subsequently, isopropyl ␤-D-1-thiogalactopyranoside (IPTG; Sigma) was added to the culture to a final concentration of 1 mM, and the culture was allowed to grow at 18°C for 12 h. Then, the cells were collected by centrifugation (13,000 rpm) at 4°C and resuspended in 25 ml of protein extract buffer (50 mM Tris-HCl, pH 7.5, 100 mM NaCl, and 1 mM EDTA) that was supplemented with the protease inhibitor phenylmethylsulfonyl fluoride ([PMSF] 10 mM). The cells were briefly lysed by sonication with a Sonifier 250 (Branson Digital Sonifier, Branson, USA), and the cell lysate was centrifuged at 13,000 rpm at 4°C for 30 min. Soluble protein fractions were collected and mixed with preequilibrated Ni 2ϩ resin (GE Healthcare, USA) for 1 h at 4°C; the resin was then placed in a column and extensively washed with binding buffer (50 mM Na 3 PO 4 , 30 mM NaCl, and 10 mM imidazole). The desired protein was finally eluted in 50 mM Na 3 PO 4 , 30 mM NaCl, and 250 mM imidazole. Protein purity was assessed using sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE), and another purification step in which an Amicon Ultra filter unit (Millipore, USA) was used to remove imidazole as well as to exchange the storage buffer (50 mM Tris-HCl, pH 7.5, 50 mM NaCl, 0.5 mM EDTA and 5% glycerol). Finally, the protein concentration was determined using a bicinchoninic acid (BCA) protein assay kit (Sangon Biotech, China).
EMSA. An electrophoretic mobility shift assay (EMSA) was carried out as follows. Briefly, a biotinlabeled fragment that contained the HSAF promoter region was amplified by PCR using 5= biotin-labeled primers ( Table 2 ). The biotin-labeled target DNA and protein extract were incubated for 20 min at room temperature according to the protocols of a LightShift Chemiluminescent EMSA kit (Thermo Scientific, USA). Then, the reaction products were loaded onto a polyacrylamide gel, electrophoresed, transferred to a nylon membrane, and cross-linked. Finally, the biotinylated DNA fragments were treated with a chemiluminescent nucleic acid detection module and detected using a VersaDoc imaging system (Bio-Rad, USA).
Bacterial two-hybrid assay. A BacterioMatch II two-hybrid system was used to determine the potential interaction of two proteins. In detail, the encoding region for each target protein was cloned into pBT (containing a chloramphenicol resistance gene) and pTGR (containing a tetracycline resistance gene). Then, the two constructions were cotransformed into the E. coli reporter strain XL1-Blue MRF= Kan, which is kanamycin resistant. If the bait protein interacts with the target protein, the transcription of the HIS3 reporter gene will be activated, producing imidazoleglycerol-phosphate dehydratase. As a result, the cotransformed strain could grow in the presence of the compound 3-amino-1,2,4-triazole (3-AT), which is a competitive inhibitor of the product of the HIS3 gene. A second reporter gene, aadA, encoding a protein that confers streptomycin (Str) resistance, provides an additional mechanism to validate the protein-protein interaction. In this experiment, the cotransformed cells were spotted on the selective medium, which is a minimal medium (M9)-based medium containing 5 mM 3-AT, 12.5 g/ml Str, 12.5 g/ml tetracycline, 34 g/ml chloramphenicol, and 30 g/ml kanamycin. Furthermore, the vectors, pBT-GacS and pTRG-GacS were constructed in this work (Table 1) , and the cotransformant containing both vectors served as a positive control because the cytoplasmic domain of GacS from Pseudomonas aeruginosa is known to interact with itself (33) . The cotransformant containing the empty pTRG and pBT vectors was used as a negative control in this study. All cotransformants were spotted onto the selective medium and grown at 28°C for 3 to 4 days and then photographed. LB agar is a nonselective medium containing 12.5 g/ml tetracycline, 34 g/ml chloramphenicol, and 30 g/ml kanamycin. The purpose of this medium is to ensure that both vectors are successfully transformed into the host E. coli XL1-Blue MRF= Kan.
